Form 4: BioCardia Director Krasno Acquires Stock Options
SEC Form 4
Director Richard M. Krasno acquired stock options in BioCardia, Inc. on October 11, 2024.
Summary
- Richard M. Krasno, a director of BioCardia, Inc., reported a transaction involving derivative securities.
- On October 11, 2024, Krasno acquired stock options for 829 shares of common stock at an exercise price of $2.65.
- The options vest and become exercisable one year from the grant date, contingent on continued service.
- Following the transaction, Krasno directly owns 3,313 derivative securities.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of stock option acquisition.
Positives
- The acquisition of stock options by a director may signal confidence in the company's future performance.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors for signals about management's view of the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 10/11/2024 | Date of stock option grant and transaction. |
| 10/11/2034 | Expiration date of the stock options. |
| 10/16/2024 | Date of signature on the Form 4 filing. |
Keywords
stock options, derivative securities, Form 4, BioCardia, BCDA, Krasno, director, acquisition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.